Acute migraine treatment outcome measures: a clinician's view.
about
Efficacy, speed of action and tolerability of almotriptan in the acute treatment of migraine: pooled individual patient data from four randomized, double-blind, placebo-controlled clinical trials.Resolution of concentration-response differences in onset of effect between subcutaneous and oral sumatriptan.The challenge of evidence-based migraine therapy.Drug comparisons: why are they so difficult?New paradigms in the recognition and acute treatment of migraine.Assessing health-related quality of life in patients with migraine.Communicating the right therapy for the right patient at the right time: acute therapy.Biomarkers in drug discovery and development: from target identification through drug marketing.Responsiveness of efficacy endpoints in clinical trials with over the counter analgesics for headache.Patient preference in clinical trials for headache medication: the patient's view.Migraine medication attributes important for patient compliance: concerns about side effects may delay treatment.Intravenous dipyrone for the acute treatment of episodic tension-type headache: a randomized, placebo-controlled, double-blind study.Almotriptan is an effective and well-tolerated treatment for migraine pain: results of a randomized, double-blind, placebo-controlled clinical trial.Intravenous magnesium sulphate in the acute treatment of migraine without aura and migraine with aura. A randomized, double-blind, placebo-controlled study.What do patients with migraine want from acute migraine treatment?Almotriptan increases pain-free status in patients with acute migraine treated in placebo-controlled clinical trials.Almotriptan increases sustained pain-free outcomes in acute migraine: results from three controlled clinical trials.Comparison of therapeutic gain with therapeutic ratio for the assessment of selective 5HT(1B/1D) agonist efficacy in migraine.Patient preference for eletriptan 80 mg versus subcutaneous sumatriptan 6 mg: results of a crossover study in patients who have recently used subcutaneous sumatriptan.
P2860
Q33237366-869473AD-9729-4BB5-9C64-02C023F4D8C3Q33987764-2FF5B129-6D7D-47DC-8849-442391F52EBDQ34155931-ABD227A2-35E8-47EC-AE30-7473AE76E7B3Q34155949-9C97E1A2-53A8-44C3-98E0-057B95C68F48Q34634345-A99D6E45-567E-4783-9B4E-A8E69B1B7C18Q34759967-19C6603C-0C98-4861-ADAB-9DF4430D4270Q34760003-F288AF0A-1974-4711-B1B9-B89AF8051201Q35118033-004BA826-9784-40E6-807D-84FC3DF93B32Q39245487-DDF36DCC-B822-41AB-869D-3FB166F759D1Q39381589-79912FB5-A0E4-4875-BE1D-CF29564EFDE7Q39392586-FE3AD35A-36E9-46DD-BDAF-AD8F4D810123Q39401249-15D6E2BE-75B2-44F0-871B-FDFD2EED18C7Q39404886-92462F07-11C6-4253-A0C5-2E792B85B03DQ39405242-7B7E817E-7436-495D-8B11-1A620BC57310Q39408073-0A2B5ADA-F012-45F9-B1F2-3FDF47152E47Q43967356-EC27AD79-2793-41A9-8476-3605D5EA3F34Q43989440-4E4C6712-DA2C-45BA-B1CD-C08C611DFE59Q44249106-09BCDEDB-B93D-43EB-A25D-A6CB3BA4CDDDQ45243683-9D2BA511-7BE5-4AFD-94CE-5DB6055FDBF0
P2860
Acute migraine treatment outcome measures: a clinician's view.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Acute migraine treatment outcome measures: a clinician's view.
@ast
Acute migraine treatment outcome measures: a clinician's view.
@en
Acute migraine treatment outcome measures: a clinician's view.
@nl
type
label
Acute migraine treatment outcome measures: a clinician's view.
@ast
Acute migraine treatment outcome measures: a clinician's view.
@en
Acute migraine treatment outcome measures: a clinician's view.
@nl
prefLabel
Acute migraine treatment outcome measures: a clinician's view.
@ast
Acute migraine treatment outcome measures: a clinician's view.
@en
Acute migraine treatment outcome measures: a clinician's view.
@nl
P2860
P1433
P1476
Acute migraine treatment outcome measures: a clinician's view.
@en
P2093
P2860
P356
10.1046/J.1468-2982.2000.0200S2014.X
P407
P478
20 Suppl 2
P577
2000-01-01T00:00:00Z